News & Analysis
Turkey continues to hurt Global markets – U.S. & European stocks lower; Gold breaks below 1200 on USD rally; Risk fights back to JPY
Upcoming high impact news:
18:30 GBP Average Earnings Index
18:30 GBP Unemployment Rate (MED)
19:00 EUR Average Earnings Index – German ZEW Economic Sentiment (MED)
Markets continued lower overnight as issues in Turkey dragged on. “Turkey’s problems are so big that they will require something very special to short-circuit the crisis,” says Jose Luis Daza, chief investment officer at QSR Capital Management.
The Dow Jones lost 125.44 points, Goldman Sachs and J.P. Morgan both falling more than 1%. The Dow posted its fourth straight day of losses, its longest losing streak since June.
The S&P 500 lost 0.4% as materials and energy lagged, posting its first four-day losing streak since March. The Nasdaq Composite fell 0.25%, but gains in Amazon and Apple added 1% which kept losses in check.
Materials lost 1%, led lower by shares of Mosaic, which fell 3.6%. Energy shares also fell 1.2% as US crude prices fell to 7-week lows.
“Investors are generally going to be more cautious with a story like Turkey out there,” said Jennifer Ellison, principal at BOS. “It’s going to hold people off from taking significant risk for a short period of time … but if you take a step back and look at the bigger picture, things are good.”
The Turkish lira, at one point lost up to 20% during Friday’s session, reached a fresh record low on Monday before paring some losses. Turkey’s central bank tried to assure global investors’ fears on Monday, stating it will provide as much liquidity as needed to the country’s banks. The central bank also said it will keep monitoring the situation closely. The Turkish economy has been reeling recently as its inflation rate reached 16% last month, well above the central bank’s 5% target. – CNBC
Shares in Europe continued lower but loses where lower than Friday’s rout. The FTSE -24.56, the DAX -65.61 and the CAC just edged into the red losing 2.36 pts. Issues from Turkey continues to keep investor confidence low. Bayer lost 10.3% after parent company Monsanto was to have found to have advised cancer risks in its product roundup.
Oil traded in a volatile session tanking to new monthly lows at 65.15, before paring losses to end the session at 66.77. Traders could keep an eye on 66.15 as it continues as a low from the daily USOUSD chart.
Gold which looked to be in demand Friday was hit hard by a higher USD, prices hitting new low’s not seen since 2017. Gold dropped below 1200 hitting a session low of 1191.65. Price closed at 1193.33 a new 2018 low.
The risk majors all put in new monthly lows to the USD. The EUR and AUD putting in solid opening lower gaps. Buyers did return late in the session. The GBP and EUR closed in the positive to the USD but the AUD lost 10 pips cementing its new move back into the .72s. The USD added 22 pips after hitting new AUG lows. Risk fought back to the Yen, the AUD, EUR and GBP ending higher. After Friday’s wash out the EUR closed higher on most crosses. These might be value buys as the issues in Turkey will still keep investor and trader confidence low and any new flare-ups will most likely rattle buyers again.
Bitcoin failed to hold its rally yesterday falling away late into the session. Price dropped 321 USD back to 6147, buyers continue to hold from 6140 but buyer confidence continues to look weak. Price is slightly higher this morning at 6233.
Good Trading from Eightcap
Sources; CNBC – All times are AEST
* The information provided here has been prepared by EightCap’s team of analysts. All expressions of opinion are subject to change without notice. Any opinions made may be personal to the author and do not reflect the opinions of EightCap.
In addition to the disclaimer on our website, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. EightCap accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently, any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.
Please note that past performance is not a guarantee of or prediction of future performance. This communication must not be reproduced or further distributed without prior permission.